Novonix (NVX) Common Equity (2020 - 2025)

Novonix's Common Equity history spans 6 years, with the latest figure at $161.7 million for Q4 2025.

  • For Q4 2025, Common Equity rose 17.5% year-over-year to $161.7 million; the TTM value through Dec 2025 reached $161.7 million, up 17.5%, while the annual FY2025 figure was $161.7 million, 17.5% up from the prior year.
  • Common Equity reached $161.7 million in Q4 2025 per NVX's latest filing, up from $137.6 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $261.0 million in Q2 2022 to a low of $137.6 million in Q4 2024.
  • Average Common Equity over 5 years is $185.4 million, with a median of $172.8 million recorded in 2023.
  • Peak YoY movement for Common Equity: surged 218.89% in 2021, then fell 25.2% in 2024.
  • A 5-year view of Common Equity shows it stood at $142.0 million in 2021, then skyrocketed by 59.2% to $226.1 million in 2022, then decreased by 18.63% to $183.9 million in 2023, then dropped by 25.2% to $137.6 million in 2024, then grew by 17.5% to $161.7 million in 2025.
  • Per Business Quant, the three most recent readings for NVX's Common Equity are $161.7 million (Q4 2025), $137.6 million (Q4 2024), and $183.9 million (Q4 2023).